China Digital Biomarkers Market Size & Outlook, 2023-2030

The digital biomarkers market in China is expected to reach a projected revenue of US$ 425.6 million by 2030. A compound annual growth rate of 22.6% is expected of China digital biomarkers market from 2024 to 2030.

Revenue, 2023 (US$M)
$102.3
Forecast, 2030 (US$M)
$425.6
CAGR, 2024 - 2030
22.6%
Report Coverage
China

China digital biomarkers market highlights

  • The China digital biomarkers market generated a revenue of USD 102.3 million in 2023 and is expected to reach USD 425.6 million by 2030.
  • The China market is expected to grow at a CAGR of 22.6% from 2024 to 2030.
  • In terms of segment, wearable was the largest revenue generating type in 2023.
  • Mobile based Applications is the most lucrative type segment registering the fastest growth during the forecast period.


Digital biomarkers market data book summary

Market revenue in 2023USD 102.3 million
Market revenue in 2030USD 425.6 million
Growth rate22.6% (CAGR from 2023 to 2030)
Largest segmentWearable
Fastest growing segmentMobile based Applications
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationWearable, Mobile based Applications, Sensors
Key market players worldwideAmgen Inc, Biogen Inc, Pfizer Inc, ActiGraph, AliveCor, Koneksa Health, Altoida, Empatica, VivoSense, Ixico, Neurotrack, Aural Analytics, Sonde Health, Clario, Imagene AI, Brainomix, Kinsa, Feel Therapeutics


Other key industry trends

  • In terms of revenue, China accounted for 3.0% of the global digital biomarkers market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China digital biomarkers market is projected to lead the regional market in terms of revenue in 2030.
  • South Korea is the fastest growing regional market in Asia Pacific and is projected to reach USD 193.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Digital Biomarkers Market Scope

Digital biomarkers market segmentation & scope
Wearable
Mobile based Applications
Sensors
Others
Diagnostic digital biomarkers
Monitoring digital biomarkers
Predictive and Prognostic digital biomarkers
Others
Cardiovascular and metabolic disorders (CVMD)
Respiratory disorders
Psychiatric disorders
Sleep & Movement Disease
Neurological disorders
Musculoskeletal disorders
Others
Healthcare companies
Healthcare Providers
Payers
Others

Digital Biomarkers Market Companies

Name Profile # Employees HQ Website

China digital biomarkers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital biomarkers market will help companies and investors design strategic landscapes.


Wearable was the largest segment with a revenue share of 40.47% in 2023. Horizon Databook has segmented the China digital biomarkers market based on wearable, mobile based applications, sensors covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to China digital biomarkers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China digital biomarkers market databook

  • Our clientele includes a mix of digital biomarkers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China digital biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into China digital biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China digital biomarkers market size, by type, 2018-2030 (US$M)

China Digital Biomarkers Market Outlook Share, 2023 & 2030 (US$M)

China digital biomarkers market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more